CLINICAL_TRIALS
trial_result
· 2021-11-24
Clinical Trial Update: China-Administration of Nicorandil Group（CHANGE） [Phase 4]
Summary
A Phase 4 clinical trial update from CHANGE assessed nicorandil in patients with myocardial infarction undergoing percutaneous coronary intervention.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chinese PLA General Hospital | Conditions: Myocardial Infarction, Percutaneous Coronary Intervention | Phase 4 | Status: COMPLETED